Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers

(a) On February 17, 2021, Dr. Daniel C. Stanzione notified Quest Diagnostics Incorporated (the "Company") that he has decided not to stand for re-election to the board of directors (the "Board") of the Company at the end of his current term that ends at the Company's 2021 Annual Meeting of Stockholders, which is scheduled for May 21, 2021 (the "Annual Meeting"). Dr. Stanzione currently serves as the Board's Lead Independent Director, the Chair of the Executive Committee and Governance Committee and a member of the Audit and Finance Committee and Cybersecurity Committee.

Item 7.01 Regulation FD Disclosure

Attached hereto as Exhibit 99.1 and incorporated herein by reference is a press release announcing the matters described in Item 5.02 and Item 8.01 herein.

Item 8.01 Other Events

In connection with Dr. Stanzione's decision not to stand for re-election to the Board, on February 17, 2021, the Board's independent directors selected Timothy M. Ring to serve as the Board's new Lead Independent Director, effective as of the Annual Meeting. The Board also selected Mr. Ring to Chair the Board's Governance and Executive Committees and Ms. Vicky B. Gregg to Chair the Board's Compensation Committee, each effective as of the Annual Meeting.

Item 9.01 Financial Statements and Exhibits



        Exhibit  Description
        99.1*      Press Release issued by the Company, dated February 23, 2021,
                 announcing described in this Current Report on Form 8-K
        104*     The cover page from this Current Report on Form 8-K, formatted
                 in Inline XBRL.


*     Filed herewith.









   2

© Edgar Online, source Glimpses